Aerosp Med Hum Perform. 2023 Dec 1;94(12):939-943. doi: 10.3357/AMHP.6342.2023.
ABSTRACT
INTRODUCTION: Management of aeromedical risk is essential for flight safety. Given the many operator stressors for pilots, militaries maintain a vested interest in selecting aircrew applicants who meet rigorous initial medical standards. Very little published literature exists regarding the extent of medical disqualifications or precluding conditions for initial candidates.METHODS: For the British Army, pilot selection is a phased, multistep process that includes Phase I medical screening followed by a comprehensive Phase II medical exam. De-identified summary data were retrospectively reviewed for medical fitness and disqualifying categories for the 5-yr period of 2018-2022, inclusive. For those ultimately deemed unfit for aviation service, etiology was grouped into general categories.RESULTS: Approximately one-third (30.2%) of candidates were disqualified at Phase I initial medical screening with leading categories of attrition due to respiratory etiology, especially a history of asthma or reactive airway disease, followed by ophthalmology. For the Phase II medical exam cohort, 21.0% were medically disqualified with most attrition from anthropometry and ophthalmology. There were no statistical differences in disqualifications for gender or pathway of entry (civilian vs. serving personnel).DISCUSSION: Major categories of medical attrition were similar to that of other nations, yet the published literature in this area is surprisingly tenuous. Given the desire for evidence-based medical selection standards, it is important for regular review of processes and standards such that the risks of known physiological challenges are judiciously weighed with the benefits of a large, diverse pool of selection as well as force structure and recruitment demand.Adams MS, Goldie CE, Gaydos SJ. Retrospective analysis of medical attrition for pilot applicants to the British Army Air Corps. Aerosp Med Hum Perform. 2023; 94(12):939-943.
PMID:38176043 | DOI:10.3357/AMHP.6342.2023
